ACCD stock forecast
Our latest prediction for Accolade Inc's stock price was made on the Jan. 9, 2023 when the stock price was at 7.74$.
In the short term (2weeks), ACCD's stock price should underperform the market by -1.52%. During that period the price should oscillate between -9.10% and +6.68%.
In the medium term (3months), ACCD's stock price should underperform the market by -6.64%. During that period the price should oscillate between -28.27% and +12.40%.
Get email alertsCreate a solid portfolio with ACCD
About Accolade Inc
Accolade, Inc. of Pennsylvania provides healthcare related information for self-insured companies. The Company assists employees and their families to make healthcare decisions through its health assistants. Accolade serves customers in the United States.
At the moment the company generates 457M USD in revenues.
On its last earning announcement, the company reported a loss of -5.80$ per share.
The book value per share is 7.67$
Three months stock forecastJan. 9, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 457M | 36.41% | -462M | -101.10% | -114M | -5.80 | - | - | 72M | 7.67 | - | - | - |